Paroxetine binding in the blood platelets of post-traumatic stress disorder patients
- PMID: 8366759
- DOI: 10.1016/0024-3205(93)90444-8
Paroxetine binding in the blood platelets of post-traumatic stress disorder patients
Abstract
Platelet serotonin (5-HT) uptake, as determined by 3H-paroxetine (PA) binding, was studied in 20 Post-traumatic Stress Disorder (PTSD) patients and 20 normal controls. Kd (an inverse measure of affinity of 3H-PA binding to uptake sites) and Bmax (maximum number of 3H-PA binding sites) of 3H-PA binding were significantly decreased in PTSD patients as compared to normal controls. However, there was no difference in Kd or Bmax between PTSD patients with and without a diagnosis of major depression. The Bmax of 3H-PA binding was negatively correlated with state dependent anxiety score whereas Kd was positively correlated with the Mississippi Scale for Combat-Related PTSD score. The role of serotonergic processes in the psychobiology of PTSD is discussed.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
